John A Orwin

Director · 7 filings · Latest: Jun 15, 2026

ANAPTYSBIO, INC

First Tracks Biotherapeutics, Inc.

Travere Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TRAX	John A Orwin	Director	Jun 15, 2026	Option Exercise	$0.00	6,030	—	16,695	Jun 17 8:05 PM
ANAB	John A Orwin	Director	Jun 15, 2026	Option Exercise	$0.00	6,030	—	16,695	Jun 17 8:05 PM